Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-690P is a pseudogene member of the U6 small nuclear RNA family. U6 snRNA molecules are highly conserved non-coding RNAs central to the function of the spliceosome, the ribonucleoprotein complex responsible for splicing precursor messenger RNA (pre-mRNA) in eukaryotic cells[1][3]. However, RNU6-690P itself is a non-functional genomic copy (pseudogene), meaning it does not produce an active snRNA, and has no demonstrated biological or clinical role. Pseudogenes like RNU6-690P are common for snRNA genes, reflecting the evolutionary importance and genomic redundancy of the U6 family[3][5][6]. There is no evidence for protein-coding activity, regulatory roles, or interaction with drugs or diseases for RNU6-690P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 690, pseudogene (RNU6-690P).